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Background
The formation of protein-protein complexes of the
transmembrane receptor integrin and galactoside binding
protein galectin assist in adhesion by bridging between
cells or cells and the extracellular matrix and form adhe-
sive networks. When HIV is present the galectin bridges
between the CD4 co receptor and gp120 ligands thus
facilitating HIV infection of the T cell. The main aim of
this study is to investigate the interaction of galectin-3
with glycoligands, integrin, natural compound curcumin
and its analogs.
Methods
The structures of proteins were obtained from PDB
whereas natural compound curcumin and their analogs
have been fetched from PubChem and Drug Bank data-
bases. ZDOCK, FireDock algorithms were used to pre-
dict the protein-protein complex and molecular docking
studies were carried out using Hex8 and Discovery
Studio.
Results
Analysis of the results reveals that the glycoligand
3-aGal-LacNAc was found to bind with the CRD of
galectin-3 showing interactions with amino acids
GLN150, LYS176 and TRP181. The curcumin analog 11
was found to bind with amino acids like ARG144,
ARG162, SER237, GLU184 and ASN119 which forms
part of CRD of galectin-3. Analysis of the docking poses
of protein-protein complexes reveals that the CRD of
galectin-3 is the most probable binding interface for
integrin molecule.
Conclusion
The knowledge of the mechanism of interaction
between integrin and galectin may provide important
therapeutic opportunities and the proposed compounds
may act as a scaffold for drug design against HIV
infection.
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